Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

450 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathology, Diagnosis, and Management of Sarcoma.
Miwa S, Hayashi K, Demura S. Miwa S, et al. Among authors: demura s. Int J Mol Sci. 2024 Jun 15;25(12):6609. doi: 10.3390/ijms25126609. Int J Mol Sci. 2024. PMID: 38928315 Free PMC article.
The Therapeutic Effect and Clinical Outcome of Immune Checkpoint Inhibitors on Bone Metastasis in Advanced Non-Small-Cell Lung Cancer.
Asano Y, Yamamoto N, Demura S, Hayashi K, Takeuchi A, Kato S, Miwa S, Igarashi K, Higuchi T, Yonezawa H, Araki Y, Morinaga S, Saito S, Sone T, Kasahara K, Tsuchiya H. Asano Y, et al. Among authors: demura s. Front Oncol. 2022 Apr 1;12:871675. doi: 10.3389/fonc.2022.871675. eCollection 2022. Front Oncol. 2022. PMID: 35433422 Free PMC article.
Novel predictors of immune checkpoint inhibitor response and prognosis in advanced non-small-cell lung cancer with bone metastasis.
Asano Y, Yamamoto N, Demura S, Hayashi K, Takeuchi A, Kato S, Miwa S, Igarashi K, Higuchi T, Taniguchi Y, Morinaga S, Sone T, Okuda M, Matsumoto I, Yano S, Tsuchiya H. Asano Y, et al. Among authors: demura s. Cancer Med. 2023 Jun;12(11):12425-12437. doi: 10.1002/cam4.5952. Epub 2023 Apr 19. Cancer Med. 2023. PMID: 37076988 Free PMC article.
What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?
Miwa S, Hayashi K, Taniguchi Y, Asano Y, Demura S. Miwa S, et al. Among authors: demura s. Curr Treat Options Oncol. 2024 Jun;25(6):784-797. doi: 10.1007/s11864-024-01206-3. Epub 2024 May 16. Curr Treat Options Oncol. 2024. PMID: 38750399 Review.
Combination therapy with immune checkpoint inhibitors and denosumab improves clinical outcomes in non-small cell lung cancer with bone metastases.
Asano Y, Yamamoto N, Demura S, Hayashi K, Takeuchi A, Kato S, Miwa S, Igarashi K, Higuchi T, Taniguchi Y, Okuda M, Matsumoto I, Yano S, Tsuchiya H. Asano Y, et al. Among authors: demura s. Lung Cancer. 2024 Jul;193:107858. doi: 10.1016/j.lungcan.2024.107858. Epub 2024 Jun 19. Lung Cancer. 2024. PMID: 38901176
The Role of Microsurgery and Fluorescent-reporter Genes in Establishing Mouse Models for Real-Time Imaging of Metastatic Cancer-Cell Trafficking and Colony Formation: A Revolutionary and Disruptive Technology for Metastasis Research.
Morinaga S, Yamamoto N, Yamauchi K, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: demura s. Cancer Diagn Progn. 2024 Sep 1;4(5):544-557. doi: 10.21873/cdp.10362. eCollection 2024 Sep-Oct. Cancer Diagn Progn. 2024. PMID: 39238629 Free PMC article. Review.
450 results